Peptide-based antimicrobial effect against carbapenem-resistant Acinetobacter baumannii: preclinical drug assessment and translational potential.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide-based antimicrobial effect against carbapenem-resistant Acinetobacter baumannii: preclinical drug assessment and translational potential.
- Published In:
- Frontiers in pharmacology, 17, 1732644 (2026)
- Authors:
- Lee, Hak Jun, Lee, Seung Jun, Sung, Yoon Hyun, Park, Seung Min, Choi, Seung Pyo, Kim, Yangmee, Yoon, Young Kyung
- Database ID:
- RPEP-15497
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15497APA
Lee, Hak Jun; Lee, Seung Jun; Sung, Yoon Hyun; Park, Seung Min; Choi, Seung Pyo; Kim, Yangmee; Yoon, Young Kyung. (2026). Peptide-based antimicrobial effect against carbapenem-resistant Acinetobacter baumannii: preclinical drug assessment and translational potential.. Frontiers in pharmacology, 17, 1732644. https://doi.org/10.3389/fphar.2026.1732644
MLA
Lee, Hak Jun, et al. "Peptide-based antimicrobial effect against carbapenem-resistant Acinetobacter baumannii: preclinical drug assessment and translational potential.." Frontiers in pharmacology, 2026. https://doi.org/10.3389/fphar.2026.1732644
RethinkPeptides
RethinkPeptides Research Database. "Peptide-based antimicrobial effect against carbapenem-resist..." RPEP-15497. Retrieved from https://rethinkpeptides.com/research/lee-2026-peptidebased-antimicrobial-effect-against
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.